Improved treatment of vulvovaginal candidiasis with Clotrimazole plus probiotic Lacidophilin Vaginal Capsules
Phase 2
Completed
- Conditions
- To explore the ability of probiotic Lacidophilin Vaginal Capsules plus Clotrimazole Vaginal Tablets (500mg) in improving the treatment of uncomplicated vulvovaginal candidiasis (VVC)
- Registration Number
- TCTR20190718003
- Lead Sponsor
- Ruifang An
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 42
Inclusion Criteria
(1)20-50 years old with a history of sexual life; (2) diagnosis of uncomplicated VVC or normal vaginal microflora; (3) regular menstruation ends for at least 3 days, no vaginal irrigation or drug delivery in the vagina within 7 days and no sexual intercourse within 3 days before examination.
Exclusion Criteria
Women who had mixed vaginitis; women who was in the period of pregnancy, menstruation or lactation; women who had hysterectomy or bilateral excision of the appendix. Besides, patients with incomplete medical record were also excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sequencing results 1 month after the operation 16S rDNA sequencing
- Secondary Outcome Measures
Name Time Method Subjects’ demographics 1 month after the operation Clinical observations within 1 month after the operation